AlvaroMoreno-AspitiaMD

PubMed

• Clinical Treatment Score Post-5 Years (CTS5) and Late Recurrence Risk in Hormone Receptor-Positive, HER2-Positive Breast Cancer.
  Saranya Chumsri, Tanmayi Pai, Yaohua Ma, Zhuo Li, Angelica Gil
  Journal of the National Comprehensive Cancer Network. 2024-08-26
• The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a...
  Diogo Martins-Branco, Marie Kassapian, Véronique Debien, Rafael Caparica, Daniel Eiger
  Breast Cancer Research and Treatment. 2024-02-01
• ASO Visual Abstract: Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node-Negative T1 Triple-Negative Breast Cancer.
  Kai Huang, James Jakub, Emmanuel Gabriel, Alvaro Moreno-Aspitia, Sarah McLaughlin
  Annals of Surgical Oncology. 2023-11-01

Journal Articles

• Adjuvant Chemotherapy: To Use or Not To Use, The Anthracyclines  
  Crozier JA, Swaika A and Moreno-Aspitia A, World J Clin Oncol, 8/1/2014
• Current strategies for the prevention of breast cancer  
  Advani P and Moreno-Aspitia A, Breast Cancer: Targets and Therapy, 1/1/2014
• A church-based, Spanish language community education breast health program increases awareness and utilization of breast diagnostic services among Hispanic  
  Colon-Otero G, Albertie M, Rodriguez J, et al (Moreno-Aspitia A), Journal of Higher Education Outreach and Engagement, 1/1/2014
• A Phase II Study of AZD2171 (cediranib) in the Treatment of Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome  
  Mattison R, Jumonville A, Flynn PJ, Moreno-Aspitia A, et al, Leukemia and Lymphoma, 1/1/2014
• Overview of nanoparticle albumin-bound paclitaxel in metastatic breast cancer  
  Strauch DI, Moreno-Aspitia A, Breast Cancer Management, 5/1/2013
• The definition of IgM multiple myeloma  
  Schuster SR, Rajkumar SV, Dispenzieri A, Morice W, Aspitia AM, Ansell S, Kyle R, Mikhael J, Am J Hematol, 8/1/2011
• Triple-negative breast cancer and new treatment developments  
  Dyar S, Moreno-Aspitia A, Clinical Investigation, 8/1/2011
• A Practical Clinical Approach to Adjuvant Therapy in Breast Cancer - An Update  
  Hines SL, Tan WW, Moreno-Aspitia A, Roy V, Vallow LA, McLaughlin SA, Perez EA, US Oncol, 4/1/2009
• Author reply  
  Moreno-Aspitia A, Colon-Otero G, Cancer, 3/1/2007
• The adjuvant treatment of malignant melanomas with interferons  
  Moreno A, Maples WJ, Jacksonville Medicine, 10/1/1999
• A critical review of new treatments for the myelodysplastic syndromes  
  Colon-Otero G, Moreno A, Tefferi A, Cancer Research, Therapy & Control, 1/1/1999
• Join now to see all

Books/Book Chapters

• Diseases of the breast. 
  Chapter: Side effects of systemic therapy: neurocognitive, cardiac, and secondary malignancies. 
  Page 692 - 704Moreno Aspitia A, Perez EAEditors: Harris JR; et al.Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, PAEdition 4th,2010

Abstracts/Posters

• Clonal selection of neoplastic cells in patients with resistance to neo-adjuvant chemotherapy. Poster presentation.
  Goetz MP, Barrett M, Kalari KR, et al (Moreno-Aspitia A), San Antonio Breast Cancer Symposium, 12/1/2014
• Identification of actionable germline mutations in women newly diagnosed with high risk breast cancer enrolled in the Breast cancer genome guided therapy study (BEAUTY).
  Ellingson MS, Schahl KA, Kalari KR, et al (Moreno-Aspitia A), Individualizing Medicine: From Promise to Practice Conference, Rochester, MN, 10/6/2014
• Gene expression analysis in triple-negative breast cancers following neoadjuvant chemotherapy.
  Kalari KR, Suman VJ, Sinnwell JP, et al (Moreno-Aspitia A), Individualizing Medicine: From Promise to Practice Conference, Rochester, MN, 10/6/2014
• Evaluation of Taxane response in established xenografts derived from breast cancer patients.
  Yu J, Qin P, Yin P, et al (Moreno-Aspitia A), Individualizing Medicine: From Promise to Practice Conference, Rochester, MN, 10/6/2014
• Feasibility of using percutaneous tumor biopsies from a prospective neoadjuvant breast cancer study to develop patient derived xenografts and assess in vivo Chemothera...
  Yu J, Yin P, Gao B, et al (Moreno-Aspitia A), AACR Annual Meeting, San Diego, CA, 4/5/2014
• Analysis of sequencing data to identify potential drug targets for an individual newly diagnosed with basal breast cancer who failed to respond to current standard neo...
  Kalari KR, Tang X, Thompson KJ, et al (Moreno-Aspitia A), AACR Annual Meeting, San Diego, CA, 4/5/2014
• Transcriptome-Wide Association of MKI67 Expression Pre- and Post- Neoadjuvant Chemotherapy.
  Moyer AM et al (Moreno-Aspitia A), United States & Canadian Academy of Pathology (USCAP) Annual Meeting, San Diego, CA, 3/1/2014
• Patient derived xenografts (PDX) from breast cancer patients before and after neoadjuvant chemotherapy: a prospective study.
  Boughey JC, Yu J, Ping Yin P, et al (Moreno-Aspitia A), Clin Oncol; ASCO, 1/1/2014
• Integration of next generation sequencing (NGS) and patient derived xenografts (PDX) to identify novel markers of paclitaxel (T) response in the Breast Cancer Genome G...
  Goetz MP, Boughey JC, Kalari KR, et al (Moreno-Aspitia A), Cancer Res, San Antonio Breast Cancer Symposium, 12/15/2013
• Safety and Quality of Care Improvement via Inpatient Chemotherapy Order Standardization.
  Maddox R, Fowler K, Vendrell N, et al (Moreno-Aspitia A), Mayo Clinic’s “Value Symposium”, Jacksonville, FL, 10/30/2013
• Personalized single-patient pathway analysis of signatures associated with response to neoadjuvant chemotherapy for breast cancer.
  Sicotte H, Kalari KR, Tang X, et al (Moreno-Aspitia A), Mayo Clinic’s “Individualizing Medicine to Practice” Conference, 9/30/2013
• Meta-analysis of deep sequencing data for an individual diagnosed with basal breast cancer.
  Kalari KR, Tang X, Thompson KJ, et al (Moreno-Aspitia A), Mayo Clinic’s “Individualizing Medicine to Practice” Conference, 9/30/2013
• Estimation of tumor purity and clonal diversity from whole-exome DNA sequencing (WES) obtained from breast cancer core needle biopsies in women with newly diagnosed lo...
  Larson NB, PhD1, Sinnwell JP, Sicotte H, et al (Moreno-Aspitia A), Mayo Clinic’s “Individualizing Medicine to Practice” Conference, 9/30/2013
• N0937(Alliance): Final clinical results and correlative data from the phase II trial of cisplatin (C) and the novel agent brostallicin (B) in patients with metastatic ...
  Moreno-Aspitia A, Liu H, Hillman D, et al, ASCO, 1/1/2013
• Crozier JA, Necela BM, Thompson EA, Geiger J, Moreno-Aspitia A, et al, ASCO, 1/1/2013
• Intra-csf topotecan (topo) treatment in patients with neoplastic meningitis (nm) associated with 'responsive' malignancies.
  Jaeckle KA, Anderson SK, Willson A, Moreno-Aspitia A, Colon-Otero G, Patel T, Perez E, Neuro-oncol, 10/1/2012
• CALGB 40502/NCCTG N063H: Randomized phase III trial of weekly paclitaxel (P) compared to weekly nanoparticle albumin bound nab-paclitaxel (NP) or ixabepilone (Ix) with...
  Rugo HS, Barry WT, Moreno-Aspitia A, Lyss AP, Cirrincione C, Mayer EL, Naughton M, Layman RM, Carey LA, Somer RA, Perez EA, Hudis C, Winer EP, J Clin Oncol, 6/1/2012
• Personalized Medicine in Breast Cancer
  Moreno-Aspitia A, Global Biomarkers Consortium Annual Conference, Orlando, FL, 3/1/2012
• Phase I study of panobinostat (LBH489) and letrozole in postmenopausal women with metastatic breast cancer.
  Tan W, Allred JB, Moreno-Aspitia A, Northfelt DW, Ingle JN, Perez EA, J Clin Oncol, ASCO Annual Meeting Proceedings, 1/1/2012
• Phase II study of AZD2171 for the treatment of patients with myelodysplastic syndromes [Abstract 6570].
  O'Mahar SE, Jumonville A, Flynn PJ, Moreno-Aspitia A, et al, J Clin Oncol, 1/1/2012
• Randomized phase II study of two doses of pixantrone in patients with metastatic breast cancer, N1031 Alliance.
  Sideras K, Moreno-Aspitia A, Tenglin RC, Liu H, Lingle WL, Reinholz MM, Halling KC, Chen B, Gross G, Mowat RB, Dakhil SR, Perez EA, J Clin Oncol, 1/1/2012
• Phase II Trial of Brostallicin and Cisplatin in Patients with Metastatic Triple Negative Breast Cancer.
  Moreno-Aspitia A, Rowland KM, Liu H, et al, SABCS, 1/1/2012
• A phase II trial of rituximab for peripheral neuropathy associated with monoclonal gammopathy of undetermined significance (MGUS).
  Smith BE, Suarez GA, Witzig TE, Stevens JC, Bosch EP, Ross MA, Rubin DI, Dyck PJB, Boylan KB, Gornet MK, Fonseca R, Moreno-Aspitia A, Hentz JG, J Peripher Nerv Syst, 9/1/2011
• Phase II study of AZD2171 for the treatment of patients with acute myelogenous leukemia.
  Juckett M, LaPlant B, Flynn PJ, Jumonville A, Moreno-Aspitia A, Erlichman C, J Clin Oncol, 5/1/2011
• N0937: Phase II Trial of Brostallicin and Cisplatin in Patients with Metastatic Triple Negative Breast Cancer from the N9831 Clinical Trial.
  Moreno-Aspitia A, Rowland KM, Liu H, et al, SABCS, 1/1/2011
• Join now to see all

Lectures

• Advances in Breast Cancer Treatment 
  Jacksonville, FL - 10/4/2014
• Metastatic Breast Cancer 
  Mayo Clinic, Jacksonville, FL - 1/1/2014
• Introduction to Chemotherapy 
  Mayo Clinic, Jacksonville, FL - 1/1/2014
• Breast Cancer - Adjuvant therapy. 
  Mayo Clinic, Jacksonville, FL - 1/1/2014
• Early Stage Breast Cancer (Annual Talk) 
  Mayo Clinic, Jacksonville, FL - 1/1/2014
• Florida Doctor 
  Jacksonville, FL - 10/1/2012
• Medical Oncology 2012 
  Asuncion, Paraguay - 4/1/2012
• Breast Cancer Adjuvant Therapy 2012 
  Asuncion, Paraguay - 4/1/2012
• Personalized Medicine in Breast Cancer 
  Orlando, FL - 3/1/2012
• Novel Approaches to Metastatic Breast Cancer: Integrating Options in an Evolving Setting 
  Knoxville, TN - 1/1/2012
• Management of Triple Negative Breast Cancer: Early and Metastatic 
  Ponte Vedra, FL - 11/20/2011
• What is New on the Management of triple Negative Breast Cancer 
  Amelia Island, FL - 8/1/2011
• Update on Breast Oncology 
  Amelia Island, FL - 6/1/2011
• Update on Metastatic HER2 Positive Breast Cancer 
  Tampa, FL - 4/1/2011
• NCCTG Breast Committee Study Portfolio 
  Rochester, MN - 10/1/2010
• Update in the Adjuvant Treatment of HER2 Negative Breast Cancer 
  Amelia Island, FL - 8/1/2010
• Monoclonal Gammopathy, What do I do with it? 
  Amelia Island, FL - 6/1/2010
• Chronic Lymphoid Leukemias and its Variants 
  Mayo Clinic, Jacksonville, FL - 1/1/2010
• Caring for the Breast Cancer Patient 
  Boca Raton, FL - 8/1/2009
• What is New on the Treatment of Metastatic Breast Cancer? 
  Amelia Island, FL - 8/1/2009
• Management of Adjuvant and Metastatic Breast Cancer 
  Mayo Clinic, Jacksonville, FL - 4/1/2009
• Metastatic Breast Cancer: State of the Art, Ongoing and New Trials 
  Boston, MA - 10/1/2008
• Roadmap to the Treatment of MDS Faculty 
  New York City, NY - 2/1/2008
• CME Hematology Faculty Update Meeting 
  Dallas, TX - 1/1/2008
• Best of the SABCS 2007 
  Titusville, FL - 1/1/2008
• Join now to see all

Other

• Breast Cancer Update. TV Presentations 
  Moreno-Aspitia A, CNN en Espanol
  10/1/2011
• Update on Antiangiogenic Therapy for Advanced Breast Cancer 
  Moreno-Aspitia A, Boston University School of Medicine and the Angiogenesis Foundation
  http://www.angio.org/cme/breast4.php
  1/1/2011